Skip to main content
. 2020 Feb 19;10:2947. doi: 10.1038/s41598-020-59716-7

Figure 4.

Figure 4

Narciclasine inhibited the expression of S100A8 and S100A9 in the livers of septic neonatal rats. The neonatal rats were subjected to E. coli sepsis and narciclasine (NC, 0.1, 1 and 3 mg/kg) was administered 1 hour after sepsis induction. Livers were collected 12 hours after sepsis induction. (a) The expression of S100A8 and S100A9 in the livers was determined by Immunohistochemistry. Amplification x400. (b) The protein expression of S100A8 and S100A9 in the liver was determined by western blot. The relative levels of (c) S100A8 vs β-actin, (d) S100A9 vs β-actin were determined by densitometry. The mRNA expression of (e) S100A8 and (f) S100A9 in the liver was determined by quantitative real time PCR. Data were expressed as mean ± SEM of three independent experiments and compared using ANOVA. (c,d) ***P < 0.001, compared with normal control group; #P < 0.05, ##P < 0.01, ###P < 0.001, compared with untreated sepsis group. (e,f) ###P < 0.001, compared with sham/control group; **P < 0.01, ***P < 0.001, compared with untreated sepsis group.